N

NBIX

NBIX

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
0%Bearish
Buy/Sell Ratio0% buys
BearishBullish
NBIX Live QuoteReal-time
$165.92
+$28.94(+21.13%)1M
Day Range$161.99 – $166.25
Open$163.72
Previous Close$165.31
Volume1.14M
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$16.79B
P/E Ratio (TTM)24.5
Forward P/E16.2
EPS (TTM)$6.76
Price to Book4.3
Dividend Yield0.65%
Beta (Volatility)0.33
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
52-Week RangeCurrent: $165.92 (68%)
Low: $122.14High: $186.12
Wall Street Consensus
Strong Buy
Analyst Rating
4.8/ 5.0
Target Price
$208.54+39.0% upside

Insider Buys

0

$0

Insider Sales

64

$147.28M

Total Volume

$147.28M

100 transactions

Net Activity

$147.28M

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
15CONFIDENCE

Sentiment Rating

Heavy Distribution

CEO Conviction Index

Liquidating / Profit Taking

Key Drivers

  • •Heavy distribution: sales represent 100% of total transaction value.
  • •CEO selling activity detected. Often driven by option expiration or diversification plans.
  • •Significant liquidation: total sale value exceeds $10M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
G
1

Gorman Kevin Charles

Dir

0 buys7 sells

$75.62M total

G
2

Gano Kyle

CEO

0 buys6 sells

$14.72M total

O
3

Onyia Jude

Chief Scientific Officer

0 buys6 sells

$14.28M total

C
4

Cooke Julie

CHRO

0 buys4 sells

$6.30M total

R
5

Rastetter William H

Dir

0 buys2 sells

$6.04M total

Trading History
NBIX insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Oct 30, 2026

2 weeks ago

Morrow George J

Dir

Director
Sell15.0K$155.73$2.34M

Sep 14, 2026

2 months ago

Boyer David W.

Chief Corp. Affairs Officer

C-Level
Sell826$157.45$130K

Sep 14, 2026

2 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell8.7K$-826.00$0

Sep 14, 2026

2 months ago

Abernethy Matt

CFO

CFO
Sell2.3K$157.20$363K

Sep 9, 2026

2 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell64.4K$-2154.00$0

Sep 9, 2026

2 months ago

Benevich Eric

Chief Commercial Officer

C-Level
Sell2.2K$154.61$333K

Jul 28, 2026

3 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell2.4K$-1250.00$0

Jul 28, 2026

3 months ago

Norwalk Leslie V

Dir

Director
Sell1.3K$182.01$228K

Jul 9, 2026

4 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell54.7K$-10000.00$0

Jul 9, 2026

4 months ago

Lippoldt Darin

GC

General Counsel
Sell10.0K$179.60$1.80M

Jul 10, 2026

4 months ago

Delaet Ingrid

Chief Regulatory Officer

C-Level
Sell4.4K$181.02$791K

Jul 10, 2026

4 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell16.2K$-4367.00$0

Jul 7, 2026

4 months ago

Delaet Ingrid

Chief Regulatory Officer

C-Level
Sell14.6K$178.65$2.60M

Jul 7, 2026

4 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell16.2K$-14571.00$0

Jun 26, 2026

4 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell54.7K$-10000.00$0

Jun 26, 2026

4 months ago

Lippoldt Darin

GC

General Counsel
Sell10.0K$170.15$1.70M

Jun 5, 2026

5 months ago

Sherwin Stephen A

Dir

Director
Sell25.0K$165.32$4.13M

Jun 5, 2026

5 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell15.9K$-25000.00$0

Jun 4, 2026

5 months ago

Norwalk Leslie V

Dir

Director
Sell1.3K$168.06$210K

Jun 4, 2026

5 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell2.8K$-1250.00$0

Jun 2, 2026

5 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell22.4K$-36937.00$0

Jun 2, 2026

5 months ago

Cooke Julie

CHRO

C-Level
Sell36.9K$156.22$5.77M

May 29, 2026

5 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell16.2K$-2261.00$0

May 29, 2026

5 months ago

Delaet Ingrid

Chief Regulatory Officer

C-Level
Sell2.3K$156.71$354K

Jun 1, 2026

5 months ago

Onyia Jude

Chief Scientific Officer

C-Level
Sell11.0K$160.25$1.76M

Jun 1, 2026

5 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell25.8K$-11000.00$0

May 27, 2026

5 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell25.8K$-11000.00$0

May 27, 2026

5 months ago

Onyia Jude

Chief Scientific Officer

C-Level
Sell11.0K$155.53$1.71M

May 26, 2026

5 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell7.8K$-3888.00$0

May 26, 2026

5 months ago

Boyer David W.

Chief Corp. Affairs Officer

C-Level
Sell3.9K$156.64$609K

May 19, 2026

6 months ago

Gorman Kevin Charles

Dir

Director
Sell245.1K$154.33$37.82M

May 19, 2026

6 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell511.3K$-245088.00$0

May 15, 2026

6 months ago

Pops Richard F

Dir

Director
Sell15.0K$157.65$2.36M

May 15, 2026

6 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell34.5K$-15000.00$0

May 12, 2026

6 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell2.4K$-3810.00$0

May 12, 2026

6 months ago

Norwalk Leslie V

Dir

Director
Sell3.8K$155.01$591K

Jan 16, 2026

10 months ago

Gano Kyle

CEO

CEO
Sell36.4K$132.71$4.83M

Jan 16, 2026

10 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell140.4K$-36400.00$0

Dec 15, 2025

11 months ago

Norwalk Leslie V

Dir

Director
Sell6.2K$152.78$946K

Dec 15, 2025

11 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell6.2K$-6190.00$0

Dec 8, 2025

11 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell43.4K$-4376.00$0

Dec 8, 2025

11 months ago

Lippoldt Darin

GC

General Counsel
Sell4.4K$159.65$699K

Dec 3, 2025

11 months ago

Lyons Gary A

Dir

Director
Sell15.0K$152.61$2.29M

Dec 3, 2025

11 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell120.5K$-15000.00$0

Nov 28, 2025

11 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell44.9K$-5970.00$0

Nov 28, 2025

11 months ago

Benevich Eric

Chief Commercial Officer

C-Level
Sell6.0K$151.74$906K

Nov 25, 2025

11 months ago

Morrow George J

Dir

Director
Sell15.0K$143.37$2.15M

Nov 25, 2025

11 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell7.1K$-15000.00$0

Nov 5, 2025

12 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell40.4K$-18000.00$0

Nov 5, 2025

12 months ago

Rastetter William H

Dir

Director
Sell18.0K$151.82$2.73M

Nov 4, 2025

12 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell140.4K$-300.00$0

Nov 4, 2025

12 months ago

Gano Kyle

CEO

CEO
Sell300$141.97$43K

Aug 7, 2025

15 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell514.6K$-106322.00$0

Aug 7, 2025

15 months ago

Gorman Kevin Charles

Dir

Director
Sell106.3K$126.41$13.44M

Jul 10, 2025

16 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell4.7K$-457.00$0

Jul 9, 2025

16 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell18.3K$-59819.00$0

Jul 10, 2025

16 months ago

Delaet Ingrid

Chief Regulatory Officer

C-Level
Sell457$135.00$62K

Jul 9, 2025

16 months ago

Onyia Jude

Chief Scientific Officer

C-Level
Sell59.8K$130.46$7.80M

Jul 2, 2025

16 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell18.3K$-20362.00$0

Jul 2, 2025

16 months ago

Onyia Jude

Chief Scientific Officer

C-Level
Sell20.4K$130.13$2.65M

May 27, 2025

18 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell514.6K$-9613.00$0

May 27, 2025

18 months ago

Gorman Kevin Charles

Dir

Director
Sell9.6K$120.38$1.16M

May 5, 2025

18 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell37.5K$-30000.00$0

May 5, 2025

18 months ago

Rastetter William H

Dir

Director
Sell30.0K$110.20$3.31M

Feb 13, 2025

21 months ago

Boyer David W.

Chief Corp. Affairs Officer

C-Level
Sell1.8K$116.74$208K

Feb 13, 2025

21 months ago

Delaet Ingrid

Chief Regulatory Officer

C-Level
Sell1.5K$116.71$172K

Feb 13, 2025

21 months ago

Gano Kyle

CEO

CEO
Sell2.6K$116.85$299K

Feb 13, 2025

21 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell20.2K$-1551.00$0

Feb 13, 2025

21 months ago

Cooke Julie

CHRO

C-Level
Sell1.6K$116.78$181K

Feb 13, 2025

21 months ago

Gorman Kevin Charles

Dir

Director
Sell5.8K$116.69$682K

Feb 13, 2025

21 months ago

Sherwin Stephen A

Dir

Director
Sell13.8K$116.69$1.61M

Feb 13, 2025

21 months ago

Onyia Jude

Chief Scientific Officer

C-Level
Sell2.9K$116.79$336K

Feb 13, 2025

21 months ago

Roberts Eiry

Chief Medical Officer

C-Level
Sell2.2K$116.44$258K

Feb 13, 2025

21 months ago

Lippoldt Darin

GC

General Counsel
Sell2.2K$116.76$255K

Feb 13, 2025

21 months ago

Abernethy Matt

CFO

CFO
Sell2.6K$116.86$299K

Feb 13, 2025

21 months ago

Benevich Eric

Chief Commercial Officer

C-Level
Sell2.2K$116.73$251K

Feb 10, 2025

21 months ago

Boyer David W.

Chief Corp. Affairs Officer

C-Level
Sell700$118.31$83K

Feb 10, 2025

21 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell18.8K$-700.00$0

Feb 10, 2025

21 months ago

Cooke Julie

CHRO

C-Level
Sell700$118.28$83K

Feb 10, 2025

21 months ago

Gorman Kevin Charles

Dir

Director
Sell2.3K$118.37$269K

Feb 10, 2025

21 months ago

Roberts Eiry

Chief Medical Officer

C-Level
Sell980$118.22$116K

Feb 10, 2025

21 months ago

Lippoldt Darin

GC

General Counsel
Sell911$118.25$108K

Feb 10, 2025

21 months ago

Gano Kyle

CEO

CEO
Sell980$118.39$116K

Feb 10, 2025

21 months ago

Benevich Eric

Chief Commercial Officer

C-Level
Sell980$118.31$116K

Feb 10, 2025

21 months ago

Abernethy Matt

CFO

CFO
Sell980$118.27$116K

Jan 31, 2025

21 months ago

Abernethy Matt

CFO

CFO
Sell1.3K$152.87$196K

Jan 31, 2025

21 months ago

Cooke Julie

CHRO

C-Level
Sell1.7K$152.89$266K

Jan 31, 2025

21 months ago

Gorman Kevin Charles

Dir

Director
Sell2.7K$152.93$414K

Jan 31, 2025

21 months ago

Roberts Eiry

Chief Medical Officer

C-Level
Sell1.5K$152.81$223K

Jan 31, 2025

21 months ago

Onyia Jude

Chief Scientific Officer

C-Level
Sell126$152.97$19K

Jan 31, 2025

21 months ago

Lippoldt Darin

GC

General Counsel
Sell1.3K$152.91$191K

Jan 31, 2025

21 months ago

Gano Kyle

CEO

CEO
Sell1.5K$152.87$236K

Jan 31, 2025

21 months ago

Delaet Ingrid

Chief Regulatory Officer

C-Level
Sell1.0K$150.81$158K

Jan 31, 2025

21 months ago

Boyer David W.

Chief Corp. Affairs Officer

C-Level
Sell1.1K$152.94$169K

Jan 31, 2025

21 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell18.2K$-1740.00$0

Jan 31, 2025

21 months ago

Benevich Eric

Chief Commercial Officer

C-Level
Sell1.2K$152.94$185K

Jan 27, 2025

22 months ago

Gorman Kevin Charles

Dir

Director
Sell146.1K$149.46$21.84M

Jan 27, 2025

22 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell514.6K$-146105.00$0

Jan 15, 2025

22 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell135.4K$-65000.00$0

Jan 15, 2025

22 months ago

Gano Kyle

CEO

CEO
Sell65.0K$141.50$9.20M
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
NBIX Buy Conviction0%
Industry Rank#272 of 570
Volume Contribution1.0%
Total Industry Activity$15.24B

NBIX has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%. NBIX ranks #272 in insider activity out of 570 tracked companies in its industry.

Insider Trading Summary & Commentary
Automated executive transaction analysis for NBIX

Over the last 90 days, corporate insiders at NBIX (NBIX) engaged in a total of 100 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 64 were sales. The total volume of insider trading reached $147.28M.

The net insider activity for NBIX shows a net selling bias of $147.28M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Gorman Kevin Charles (Dir), who traded 245.1K shares valued at $37.82M on May 19, 2026.

Live Market News & Developments
Aggregated real-time headlines for NBIX (NBIX)
6 updates

Neurocrine Biosciences (NBIX) Stock Still Looks Undervalued As Its 89% Run Draws Focus

Yahoo Finance9h ago

Why Neurocrine Biosciences (NBIX) Could Be 20% Undervalued On INGREZZA Momentum

Yahoo Finance10h ago

Neurocrine Biosciences, Inc. (NBIX) Stock Price, News, Quote & History

Yahoo! Finance CanadaYesterday

Neurocrine Biosciences, Inc. (NBIX) stock price, news, quote and history

Yahoo Finance Singapore4d ago

Neurocrine Biosciences, Inc. (NBIX) Stock Forecasts

Yahoo Finance4d ago

Neurocrine Biosciences (NBIX) Stock Looks Cheap After Its 55% Five Year Run

Yahoo Finance15d ago

FAQs About NBIX Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for NBIX.

Based on SEC Form 4 disclosures, the Insider Confidence Score for NBIX is currently 15/100, which reflects a heavy distribution bias. This calculation accounts for a total of 0 purchases and 64 sales by company executives over the last 90 days.

The CEO Conviction Index for NBIX is rated as "Liquidating / Profit Taking". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.